6533b821fe1ef96bd127c317

RESEARCH PRODUCT

The role of CARD15 mutations and smoking in the course of Crohn's disease in a Mediterranean area.

Irene ModestoDaniela ScimecaMario CottoneAmbrogio OrlandoL. OlivaGiuseppe CivitavecchiaFrancesca RossiValeria CriscuoliMaria Concetta RendaAurelio MaggioFilippo Mocciaro

subject

AdultMaleReoperationmedicine.medical_specialtyPathologyGenotypeNod2 Signaling Adaptor ProteinDiseaseCrohn DiseaseRecurrenceInternal medicineMedicineHumansCrohn's diseaseHepatologybusiness.industryCrohn diseaseSmokingGastroenterologymedicine.diseasePrognosisdigestive system diseasesMutation (genetic algorithm)MutationMediterranean areaFemalebusiness

description

To evaluate the role of CARD15 mutations and smoking in the main events of Crohn's disease (CD).A total of 182 patients with CD were included in a prospective study in order to evaluate the role of CARD15 mutations and smoking in the main outcomes of disease course: first operation and surgical recurrence. The following variables were evaluated in a univariable and multivariable analysis: age, sex, site of disease, pattern, smoking habit, extraintestinal manifestations, duration of disease, and CARD15 mutation. The Kaplan-Meier method for survival curves and Cox model for multivariable analysis were, respectively, used.A total of 110 patients were operated on and 32 were reoperated on. The 7-yr cumulative free rate of surgery was 42% (95% CI 34-51%). At multivariate analysis only stricturing and penetrating pattern were predictors of surgery (HR 1.7, 95% CI 1-2.8; HR 3.2, CI 1.8-5.5, respectively). The 7-yr cumulative free rate of reoperation was 75% (95% CI 0.52-0.88). At multivariable analysis in the model with any CARD15 mutation, only smoking habit at diagnosis (HR 3.6, 95% CI 1.4-9.1) was predictive of surgical recurrence. When single mutations were considered in the model smoking (HR 4.2, 95% CI 1.8-10.1) and L1007fs mutation (HR 2.9, 95% CI 1.1-7.3) were predictive of reoperation.In CD, smoking predicts recurrence after surgery. The role of CARD15 mutations in the clinical course of CD remains undefined.

10.1111/j.1572-0241.2007.01589.xhttps://pubmed.ncbi.nlm.nih.gov/18341489